 |
English
|
正體中文
|
简体中文
|
Items with full text/Total items : 12145/12927 (94%)
Visitors : 852676
Online Users : 217
|
|
|
Loading...
|
Please use this identifier to cite or link to this item:
http://ir.nhri.org.tw/handle/3990099045/10171
|
| Title: | Serum DHEA-S concentration correlates with clinical symptoms and neurocognitive function in patients with bipolar II disorder: A case-controlled study |
| Authors: | Lee, SY;Wang, LJ;Chang, CH;Wu, CC;Chen, HL;Lin, SH;Chu, CL;Lu, T;Lu, RB |
| Contributors: | Center for Neuropsychiatric Research |
| Abstract: | Objectives Dysregulation of the neuroendocrine system including dehydroepiandrosterone (DHEA), dehydroepiandrosterone sulfate (DHEA-S), and pregnenolone may play a role in the pathophysiology of bipolar II disorder (BP-II). The aims of the current study are to determine (a) the differences in DHEA, DHEA-S and pregnenolone in patients with BP-II and controls; and (b) the correlation of levels of the above hormones, cognitive function, and clinical symptoms. Methods Patients diagnosed with BP-II and healthy controls were recruited from psychiatric department. Blood samples were collected to measure the levels of DHEA, DHEA-S and pregnenolone in all participants, followed by assessment of cognitive function using the Brief Assessment of Cognition in Affective Disorders (BACA). Results A total of 32 patients BP-II and 30 healthy control subjects were recruited. The BP-II group was found with significantly elder age, fewer years of education, and lower BACA composite scores compared to the healthy controls. The level of DHEA-S was significantly associated with performance in BACA when controlling for age, gender, years of education and having BP-II (P = 0.018). The DHEA-S level was significantly correlated with mania score (r = − 0.498, P = 0.010). Conclusion Our findings support that serum level of DHEA-S may be a biomarker representing clinical manic symptoms and cognitive performance. |
| Date: | 2017-03-03 |
| Relation: | Progress in Neuro-Psychopharmacology and Biological Psychiatry. 2017 Mar 3;74:31-35. |
| Link to: | http://dx.doi.org/10.1016/j.pnpbp.2016.11.006 |
| JIF/Ranking 2023: | http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=NHRI&SrcApp=NHRI_IR&KeyISSN=0278-5846&DestApp=IC2JCR |
| Cited Times(WOS): | https://www.webofscience.com/wos/woscc/full-record/WOS:000392894700004 |
| Cited Times(Scopus): | http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=85002781942 |
| Appears in Collections: | [其他] 期刊論文
|
Files in This Item:
| File |
Description |
Size | Format | |
|---|
| SCP85002781942.pdf | | 337Kb | Adobe PDF | 438 | View/Open |
|
All items in NHRI are protected by copyright, with all rights reserved.
|
